Become an NF Patient Representative
15 January 2021
As patients and caregivers of those with Neurofibromatosis Type 1, Neurofibromatosis Type 2, or Schwannomatosis, your voices and lived experiences play an important role in determining the direction that research should take!
The REiNS (Response Evaluation in Neurofibromatosis and Schwannomatosis) Collaboration is looking for patients and caregivers to help in the fight to cure all types of NF by helping to design clinical trials. This is a chance for you to make a real difference in finding treatments for these conditions. A scientific background is not necessary – lived experience with neurofibromatosis and schwannomatosis is. We are looking for people from all backgrounds, including people of all genders, races, ethnicities, education level, and health status.
For more information about REiNS, please watch this video at
If you are interested in joining the patient representative program, please click the link below.
Filter News
Milton Keynes NF1 Medical Information Day 2026
Our Milton Keynes NF1 Medical Information Day was on 9 May 2026.
Read More
Beyond Diagnosis: Manchester Community Festival 2026
NF1 and Noonan Syndrome Community Festival. A Day connected to community, learning and curiosity.
Read More
Evie’s NF1 story
Evie's mam Emily & brother Riley are doing 5k/day during May, after Evie was diagnosed with NF1 at the age of three.
Read More
Sacred Heart Chorus and Orchestra Summer Concert
Sacred Heart Chorus and Orchestra are supporting the charity with a concert at Sacred Heart Church Wimbledon
Read More
Team NTUK London Marathon 2026
Congratulations and thank you to Team NTUK for their epic efforts!
Read More
Living with Neurofibromatosis Type 1: A Journey of Resilience, Transformation, and Impact
Our charity ambassador, Amit Ghose, shares his inspirational story.
Read More
London Marathon Motivation 2026
Find out why our Team NTUK runners are taking on the 2026 London Marathon.
Read More
Rare Disease Day 2026: Equity for Rare
A look back on Rare Disease Day: Equity for Rare, 28 February 2026.
Read More